Dose-dense and high-dose chemotherapy plus rituximab with autologous stem cell transplantation for primary treatment of diffuse large B-cell lymphoma with a poor prognosis: a phase II multicenter study

BACKGROUND: We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell lymphoma. DESIGN AND METHODS: Ninety-four young patients (age, 18–60) with stage III–IV diffuse larg...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vitolo, Umberto, Chiappella, Annalisa, Angelucci, Emanuele, Rossi, Giuseppe, Liberati, Anna Marina, Cabras, Maria Giuseppina, Botto, Barbara, Ciccone, Giovannino, Gaidano, Gianluca, Falchi, Lorenzo, Freilone, Roberto, Novero, Domenico, Orsucci, Lorella, Pavone, Vincenzo, Pogliani, Enrico, Rota-Scalabrini, Delia, Salvi, Flavia, Tonso, Anna, Tucci, Alessandra, Levis, Alessandro
Formato: Artigo
Lenguaje:Inglês
Publicado: Ferrata Storti Foundation 2009
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738717/
https://ncbi.nlm.nih.gov/pubmed/19586937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2009.007005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares